XML 35 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Text Block [Abstract]  
Stock-Based Compensation Expense on All Employee and Non-Employee Awards
The Company recognized stock-based compensation expense on all employee and
non-employee
awards as follows:
                 
 
For the three months ended March 31,
 
(in thousands)
 
2020
   
2019
 
Research and development
  $
530
    $
433
 
General and administrative
   
1,410
     
1,023
 
                 
Stock-based compensation expense
  $
1,940
    $
1,456
 
                 
 
 
 
 
Fair Value of Stock Options Assumptions Using Black-Scholes Option Valuation Model
For the three months ended March 31, 2020 and 2019, the fair value of stock options was estimated on the date of grant using a Black-Scholes option valuation model with the following assumptions:
                 
 
For the three months ended 
March 31
,
 
 
2020
 
 
2019
 
Risk-free interest rate
   
0.50
 -
 1.68%
     
2.28
 -
 2.53%
 
Expected life in years
   
6 - 6.25
     
6 - 6.25
 
Expected volatility
   
71.11
 -
 73.01%
     
78.87
 -
 85.00%
 
Expected dividend yield
   
0%
     
0%
 
 
 
 
 
Stock Option Activity under Stock Option Plan
Stock option activity under the Company’s stock option plan for the three months ended March 31, 2020 is as follows:
                                 
(in thousands, except share and per share data)
 
Number of
Shares
 
 
Weighted-
Average
Exercise Price
 
 
Weighted-
Average
Contractual
Term (Years)
 
 
Aggregate
Intrinsic Value
 
Outstanding, December 31, 2019
   
5,842,879
    $
3.21
     
     
 
Granted
   
896,000
     
4.17
     
     
 
Exercised
   
(2,333
)    
1.87
     
     
 
Cancelled
   
(59,667
)    
4.67
     
     
 
                                 
Outstanding, March 31, 2020
   
6,676,879
    $
3.95
     
8.15
    $
864
 
                                 
Options exercisable, March 31, 2020
   
3,024,728
    $
4.05
     
6.83
    $
509
 
                                 
Options exercisable, December 31, 2019
   
2,765,357
    $
     4.39
     
6.70
    $
     3,603
 
                                 
Options available for future grant
   
1,066,275
     
     
     
 
                                 
 
 
 
 
Summary of Unvested Restricted Stock
A summary of the status of unvested restricted stock for the
three
 months ended March 31, 2020 is as follows:
                 
 
Number of Shares
 
 
Weighted-Average

Grant Date Fair Value
 
Non-vested,
December 31, 201
9
   
939,636
    $
2.93
 
Granted
   
555,900
     
4.21
 
Vested
   
—  
     
—  
 
Cancelled
   
—  
     
—  
 
                 
Non-vested,
March 31, 2020
   
1,495,536
    $
     3.41